- Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes
Atziri Corin Chavez Alvarez et al, 2023, Journal of Medicinal Chemistry CrossRef - Triumphs and challenges in exploiting poly(ADP‐ribose) polymerase inhibition to combat triple‐negative breast cancer
Jonathan Wooten et al, 2023, Journal of Cellular Physiology CrossRef - Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells
Sébastien Fortin et al, 2017, Journal of Medicinal Chemistry CrossRef - Synthesis of Succinimide-Containing Chromones, Naphthoquinones, and Xanthones under Rh(III) Catalysis: Evaluation of Anticancer Activity
Sang Hoon Han et al, 2016, The Journal of Organic Chemistry CrossRef - Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma
Noble Kumar Talari et al, 2018, Journal of Neuro-Oncology CrossRef - Aryl-hydrocarbon receptor as a potential target for anticancer therapy
J.E. Vorontsova et al, 2018, Biomeditsinskaya Khimiya CrossRef - Aryl-Hydrocarbon Receptor as a Potential Target for Anticancer Therapy
J. E. Vorontsova et al, 2019, Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry CrossRef - Role of the aryl hydrocarbon receptor in carcinogenesis and potential as an anti-cancer drug target
Siva Kumar Kolluri et al, 2017, Archives of Toxicology CrossRef - In Vitro Antitumor Effects of AHR Ligands Aminoflavone (AFP 464) and Benzothiazole (5F 203) in Human Renal Carcinoma Cells
Gabriela A. Luzzani et al, 2017, Journal of Cellular Biochemistry CrossRef